- Home
- TLRY vs LDP Comparison
TLRY vs LDP Comparison
Compare TLRY & LDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLRY | LDP |
|---|---|---|
| Founded | N/A | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 628.4M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLRY | LDP |
|---|---|---|
| Price | $11.86 | $21.33 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $150.00 | N/A |
| AVG Volume (30 Days) | ★ 9.5M | 102.5K |
| Earning Date | 01-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $830,766,000.00 | N/A |
| Revenue This Year | $7.28 | N/A |
| Revenue Next Year | $4.51 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.31 | N/A |
| 52 Week Low | $3.51 | $16.16 |
| 52 Week High | $23.20 | $20.30 |
Technical Indicators
Market Signals| Indicator | TLRY | LDP |
|---|---|---|
| Relative Strength Index (RSI) | 91.51 | 47.23 |
| Support Level | $7.10 | $21.26 |
| Resistance Level | $8.64 | $21.51 |
| Average True Range (ATR) | 0.62 | 0.18 |
| MACD | 0.78 | 0.02 |
| Stochastic Oscillator | 96.31 | 66.95 |
Price Performance
Historical ComparisonAbout TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.